Preclinical Research Leader Surpass CEO Dr. Timothy J Pelura, President and CEO, PhD, is a serial life science entrepreneur and accomplished executive with more than 35 years of experience in pharmaceutical, biotech and medical device industries and has been pivotal in the development of several new drugs spanning numerous therapeutic areas. He is a respected business leader with a long successful history of growing small companies within the life sciences space. In his most recent position he served as president of BioEntrep, a strategic consultancy focused on transforming life science technologies into high value, medical products by delivering sound advice and needed capacity in the areas of finance; business, corporate and preclinical development; clinical/regulatory strategy; and corporate communications. Prior to BioEntrep, he held positions as Chairman, President and CEO of Immunome, an antibody platform company; CEO of Promedior, a product-focused biotech company developing novel therapeutics for the treatment of fibrotic diseases; CSO of Kereos responsible for all R&D activities for their oncology, cardiology, and molecular imaging programs; President and COO of Provasis Therapeutics, a developer of interventional neurosurgical devices; as well as various other roles including executive R&D positions at Neuron Therapeutics, Alliance Pharmaceutical Corp., and Pharmacia. He earned his doctorate and master's degrees in Chemistry as well as a bachelor's degree in Biological Sciences from Rutgers University.
Chief Scientific Officer, PhD, brings to Surpass more than 25 years of experience in the biopharmaceutical, interventional, medical device industries, and preclinical CRO industries. He possesses a vast level of scientific experience in discovery and development of biopharmaceutical and device products. Prior to joining Surpass, he was the Scientific Director for Charles River Laboratories Interventional and Surgical Services - Massachusetts Division. He received a PhD in Pharmaceutical Sciences from the University of Kentucky. Following post-doctoral training in cardiovascular pharmacology at the University of Michigan Medical School, he began a career in biotechnology as a Senior Scientist in Pharmacology and Toxicology at Centocor, and later at Selective Genetics as Group Leader of Pharmacology. In 1999, he made the transition from biopharmaceutical research to contract research by joining Sierra Biomedical as the Director of Pharmacology and Surgery. His area of scientific expertise is the physiology, pharmacology and pathobiology of cardiovascular disease with a specific interest in preclinical models of inflammation, cardiovascular disease and safety pharmacology. In his career he has published over 50 papers and abstracts, and has presented at national and international scientific meetings.
Test Facility Management and Sr. Director of Operations, MS, RQAP-GLP, has more than 17 years of experience in preclinical medical devices and combination products, with an extensive background in quality assurance and regulatory compliance. Her tenure in preclinical research and animal science training in addition to her regulatory and quality expertise contributes to her success at running a streamlined operation using an interdisciplinary team for executing high quality biomedical studies. She is an accomplished manager bringing more than 10 years of supervisory management experience in contract research and medical device companies. As an active member of the Society of Quality Assurance (SQA), she previously served as the Chair and Vice Chair of the Medical Device Specialty Section. Throughout her career, she has held positions in contract research organizations as well as private industry. She is a Registered Quality Assurance Professional certified in FDA, EPA, and OECD GLP regulations and received her Bachelor and Master of Science degrees in Animal Science from Sul Ross State University in Alpine, Texas.
Manager of Regulatory Compliance (and Quality Assurance), AAS, CVT, RQAP-GLP, has more than 13 years of experience working in preclinical research for medical devices and combination products at contract research organizations, with more than 8 years spent in quality assurance/regulatory compliance positions. In addition to being a registered quality assurance professional in good laboratory practice regulations (FDA, EPA, and OECD GLP) by the Society of Quality Assurance (SQA) she is also an active member of SQA and the Medical Device Specialty Section. In 2004, she obtained her certified veterinary technician license and has extensive knowledge of general animal husbandry as well as surgical and post-operative care. She received her Associate of Applied Science degree in Veterinary Technology from Argosy University-Twin Cities, Minnesota in 2003.